Trial Profile
Efficacy of a once daily combination of Elvitegravir /Cobicistat /Emtricitabine /TAF plus Darunavir (G/D) in HIV infected adults with history of prior resistance and regimen failure
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2018
Price :
$35
*
At a glance
- Drugs Cobicistat/elvitegravir/emtricitabine/tenofovir alafenamide (Primary) ; Darunavir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 18 Nov 2018 New trial record
- 07 Oct 2018 Results presented at the IDWeek 2018